Managers / Q2 2023 · view latest →
DSC Advisors, L.P.
CIK 0001299434 · 900 NORTH MICHIGAN AVENUE, SUITE 1600, CHICAGO, IL, 60611 · (312) 915-2485
Summary
Dsc Advisors, L.P. reported $67M in U.S.-listed holdings across 31 positions for Q2 2023.
The portfolio is heavily concentrated: R1 Rcm alone accounts for 23.3% of reported value.
Compared with Q1 2023, the fund opened 11 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 96.4% · $64M
- ADR · 3.5% · $2M
- Other · 0.1% · $79,200
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ABTABBOTT LABS | NEW | +41.4K | 41.4K | +$5M | $5M |
| ZVRAZEVRA THERAPEUTICS INC | NEW | +180.8K | 180.8K | +$922,080 | $922,080 |
| ADBEADOBE SYSTEMS INCORPORATED | NEW | +534 | 534 | +$261,121 | $261,121 |
| ACNACCENTURE PLC IRELAND | NEW | +813 | 813 | +$250,876 | $250,876 |
| ORCLORACLE CORP | NEW | +1.9K | 1.9K | +$228,772 | $228,772 |
| NFLXNETFLIX INC | NEW | +519 | 519 | +$228,614 | $228,614 |
| HANESBRANDS INC | NEW | +50.0K | 50.0K | +$227,000 | $227,000 |
| BRK/BBERKSHIRE HATHAWAY INC DEL | NEW | +628 | 628 | +$214,148 | $214,148 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | R1 RCM INC | COM | 23.27% | $16M | 841.0K |
| 2 | CVSCVS HEALTH CORPhistory → | COM | 15.88% | $11M | 153.2K |
| 3 | ZBHZIMMER BIOMET HOLDINGS INChistory → | COM | 13.65% | $9M | 62.5K |
| 4 | BMRNBIOMARIN PHARMACEUTICAL INChistory → | COM | 13.00% | $9M | 100.0K |
| 5 | GOOGALPHABET INC | CAP STK CL C · CAP STK CL A | 8.86% | $6M | 48.9K |
| 6 | ABTABBOTT LABShistory → | COM | 6.77% | $5M | 41.4K |
| 7 | EHTHEHEALTH INChistory → | COM | 4.58% | $3M | 380.0K |
| 8 | TEVATEVA PHARMACEUTICAL INDS LTDhistory → | SPONSORED ADS | 3.50% | $2M | 310.0K |
| 9 | VYNEVYNE THERAPEUTICS INC | COM | 0.70% | $466,900 | 115.0K |
| 10 | MSFTMICROSOFT CORP | COM | 0.55% | $365,399 | 1.1K |
| 11 | METAMETA PLATFORMS INC | CL A | 0.51% | $342,080 | 1.2K |
| 12 | VVISA INC | COM CL A | 0.46% | $306,349 | 1.3K |
| 13 | MAMASTERCARD INCORPORATED | CL A | 0.45% | $298,515 | 759 |
| 14 | ADBEADOBE SYSTEMS INCORPORATED | COM | 0.39% | $261,121 | 534 |
| 15 | ACNACCENTURE PLC IRELAND | SHS CLASS A | 0.38% | $250,876 | 813 |
| 16 | ZVRAZEVRA THERAPEUTICS INC | COM NEW | 0.38% | $250,410 | 49.1K |
| 17 | CRMSALESFORCE INC | COM | 0.38% | $250,132 | 1.2K |
| 18 | AAPLAPPLE INC | COM | 0.35% | $230,824 | 1.2K |
| 19 | ORCLORACLE CORP | COM | 0.34% | $228,772 | 1.9K |
| 20 | NFLXNETFLIX INC | COM | 0.34% | $228,614 | 519 |
| 21 | BRK/BBERKSHIRE HATHAWAY INC DEL | CL B NEW | 0.32% | $214,148 | 628 |
| 22 | EHABUSDENHABIT INC | COM | 0.17% | $115,000 | 10.0K |
| 23 | VIVID SEATS INC | COM CL A | 0.12% | $79,200 | 10.0K |
| 24 | COMSCOMSOVEREIGN HLDG CORP | COM NEW | 0.06% | $38,475 | 22.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $11M | 19 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $30M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $63M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $61M | 32 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 33 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $67M | 31 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $115M | 24 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $44M | 17 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $97M | 97 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $100M | 113 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $290M | 132 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $129M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $98M | 74 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $138M | 74 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $161M | 85 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 51 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $149M | 49 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 37 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $102M | 35 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 88 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $506M | 97 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 81 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $826M | 78 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DSCQG PR LLC028-18129
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.